UPLOAD Filing
Serina Therapeutics, Inc.
Date: April 23, 2025 · CIK: 0001708599 · Accession: 0000000000-25-004289
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286620
Letter
Re: Serina Therapeutics, Inc. Registration Statement on Form S-3 Filed April 18, 2025 File No. 333-286620 Dear Steven Ledger:
April 23, 2025
Steven Ledger Chief Executive Officer Serina Therapeutics, Inc. 601 Genome Way, Suite 2001 Huntsville, AL 35806
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Stephen Hinton
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 23, 2025 Steven Ledger Chief Executive Officer Serina Therapeutics, Inc. 601 Genome Way, Suite 2001 Huntsville, AL 35806 Re: Serina Therapeutics, Inc. Registration Statement on Form S-3 Filed April 18, 2025 File No. 333-286620 Dear Steven Ledger: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen Hinton </TEXT> </DOCUMENT>